Snežana B. Pajović

Prof. Dr. Snežana B. Pajović

Laboratory of Molecular Biology and Endocrinology, Institute of Nuclear Sciences "Vinča" National Institute for the Republic of Serbia, University of Belgrade, Belgrade, Beograd, Serbia
+1
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2020 in Molecules
Verified
Journal Article
Open access
PDF file
MSMilan Sencanski
Milan Sencanski
VPVladimir Perovic
Vladimir Perovic
Snežana B. PajovićSnežana B. Pajović
Snežana B. Pajović
MAMiroslav Adzic
Miroslav Adzic
SPSlobodan Paessler
Slobodan Paessler
SGSanja Glisic
Sanja Glisic
The SARS-CoV-2 outbreak caused an unprecedented global public health threat, having a high transmission rate with currently no drugs or vaccines approved. An alternative powerful additional approach to counteract COVID-19 is in silico drug repurposing. The SARS-CoV-2 main protease is essential for viral replication and an attractive drug target. In this study, we used the virtual screening protocol with both long-range and short-range interactions to select candidate SARS-CoV-2 main protease inhibitors. First, the Informational spectrum method applied for small molecules was used for searching the Drugbank database and further followed by molecular docking. After in silico screening of drug space, we identified 57 drugs as potential SARS-CoV-2 main protease inhibitors that we propose for further experimental testing.

23 December 2009 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
SPSnezana Pejic
Snezana Pejic
Ana TodorovicAna Todorovic
Ana Todorovic
VSVesna Stojilkovic
Vesna Stojilkovic
JKJelena Kasapović
Jelena Kasapović
Snežana B. PajovićSnežana B. Pajović
Snežana B. Pajović
Oxidative stress and impaired antioxidant system have been proposed as a potential factors involved in the pathophysiology of diverse disease states, including carcinogenesis. In this study, we explored the lipid peroxidation levels and antioxidant enzyme activities in women diagnosed with different forms of gynecological diseases in order to evaluate the antioxidant status in endometrium of such patients.

7 August 2018 in Molecules
Verified
Journal Article
Open access
PDF file
NĐNeda Đorđević
Neda Đorđević
NVNevena Todorović Vukotić
Nevena Todorović Vukotić
INIrena Novaković
Irena Novaković
LPLato Pezo
Lato Pezo
BPBoris PEJIN
Boris PEJIN
Snežana B. PajovićSnežana B. Pajović
Snežana B. Pajović
Screens of antioxidant activity (AA) of various natural products have been a focus of the research community worldwide. This work aimed to differentiate selected samples of Merlot wines originated from Montenegro, with regard to phenolic profile and antioxidant capacity studied by survival rate, total sulfhydryl groups and activities of glutathione peroxidase (GPx), glutathione reductase and catalase in H2O2–stressed Saccharomyces cerevisiae cells. In this study, DPPH assay was also performed. Higher total phenolic content leads to an enhanced AA under both conditions. The same trend was observed for catechin and gallic acid, the most abundant phenolics in the examined wine samples. Finally, the findings of an Artificial Neural Network (ANN) model were in a good agreement (r2 = 0.978) with the experimental data. All tested samples exhibited a protective effect in H2O2–stressed yeast cells. Pre-treatment with examined wines increased survival in H2O2–stressed cells and shifted antioxidative defense towards GPx–mediated defense. Finally, sensitivity analysis of obtained ANN model highlights the complexity of the impact that variations in the concentrations of specific phenolic components have on the antioxidant defense system.

4 June 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
SĐSiniša Đurašević
Siniša Đurašević
SPSnezana Pejic
Snezana Pejic
IGIlijana Grigorov
Ilijana Grigorov
GNGorana Nikolić
Gorana Nikolić
DMDragana Mitić-Ćulafić
Dragana Mitić-Ćulafić
Zoran TodorovicZoran Todorovic
Zoran Todorovic
Thioacetamide (TAA) is widely used to study liver toxicity accompanied by oxidative stress, inflammation, cell necrosis, fibrosis, cholestasis, and hepatocellular carcinoma. As an efficient free radical’s scavenger, C60 fullerene is considered a potential liver-protective agent in chemically-induced liver injury. In the present work, we examined the hepatoprotective effects of two C60 doses dissolved in virgin olive oil against TAA-induced hepatotoxicity in rats. We showed that TAA-induced increase in liver oxidative stress, judged by the changes in the activities of SOD, CAT, GPx, GR, GST, the content of GSH and 4-HNE, and expression of HO-1, MnSOD, and CuZnSOD, was more effectively ameliorated with a lower C60 dose. Improvement in liver antioxidative status caused by C60 was accompanied by a decrease in liver HMGB1 expression and an increase in nuclear Nrf2/NF-κB p65 ratio, suggesting a reduction in inflammation, necrosis and fibrosis. These results were in accordance with liver histology analysis, liver comet assay, and changes in serum levels of ALT, AST, and AP. The changes observed in gut microbiome support detrimental effects of TAA and hepatoprotective effects of low C60 dose. Less protective effects of a higher C60 dose could be a consequence of its enhanced aggregation and related pro-oxidant role.

20 February 2024 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
NDNina Dragićević
Nina Dragićević
JPJelena Predic-Atkinson
Jelena Predic-Atkinson
BNBojan Nikolic
Bojan Nikolic
Snežana B. PajovićSnežana B. Pajović
Snežana B. Pajović
SISanja Ivkovic
Sanja Ivkovic
MAMiroslav Adzic
Miroslav Adzic
Photodynamic therapy (PDT) has gained significant attention due to its superiority over conventional treatments. In the context of skin cancers and nonmalignant skin diseases, topical application of photosensitizer formulations onto affected skin, followed by illumination, offers distinct advantages. Topical PDT simplifies therapy by providing easy access to the skin, increasing drug concentration within the target area, and confining residual photosensitivity to the treated skin. However, the effectiveness of topical PDT is often hindered by challenges such as limited skin penetration or photosensitizer instability. Additionally, the hypoxic tumor environment poses further limitations. Nanocarriers present a promising solution to address these challenges. The objective of this review is to comprehensively explore and highlight the role of various nanocarriers in advancing topical PDT for the treatment of skin diseases. The primary focus is to address the challenges associated with conventional topical PDT approaches and demonstrate how nanotechnology-based strategies can overcome these challenges, thereby improving the overall efficiency and efficacy of PDT. Nanotechnology has revolutionized the field of PDT, offering innovative tools to combat the unfavorable features of photosensitizers and hurdles in PDT. Nanocarriers enhance skin penetration and stability of photosensitizers, provide controlled drug release, reduce needed dose, increase production of reactive oxygen species, while reducing side effects, thereby improving PDT effectiveness.

17 February 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
NPNataša Popović
Nataša Popović
VSVesna Stojilkovic
Vesna Stojilkovic
SPSnezana Pejic
Snezana Pejic
Ana TodorovicAna Todorovic
Ana Todorovic
IPIvan Pavlovic
Ivan Pavlovic
Snežana B. PajovićSnežana B. Pajović
Snežana B. Pajović
This study examined the effects of lithium on gene expression and activity of the antioxidant enzymes copper zinc superoxide dismutase (SOD1), manganese superoxide dismutase (SOD2), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) in the hippocampus of chronically stressed rats. In addition, we examined the effects of lithium on anxiety behaviors, hippocampal concentrations of dopamine (DA) and malondialdehyde (MDA), protein levels of brain-derived neurotrophic factor (BDNF), tyrosine hydroxylase (TH), dopamine transporter (DAT), and catechol-O-methyltransferase (COMT), as well as activity of monoamine oxidase (MAO) in chronically stressed rats. The investigated parameters were quantified by real-time RT-PCR, Western blot analyses, and assays of enzyme activities. We found that lithium did not change gene expression of SOD1, CAT, GPx, and GR but decreased gene expression of SOD2 in chronically stressed rats. A very important result in this study was that lithium treatment decreased the enzyme activities of SOD1 and SOD2 but increased the enzyme activities of GPx and GR in stress condition, which indicates the control of redox balance. The reduced concentration of MDA confirms this. In addition, we found that lithium treatment decreased high protein levels of BDNF and DAT in chronically stressed rats to the level found in unstressed animals. Also, lithium treatment increased the expression of TH but decreased the enzyme activity of MAO B, which contributed to the increase of hippocampal concentration of DA in chronically stressed rats to the level of unstressed animals. Finally, lithium treatment in animals exposed to chronic stress increased the time spent in open arms. Lithium-induced modulation of hippocampal antioxidant status and attenuation of oxidative stress stabilized behavior in animals with high anxiety index. In addition, reduced oxidative stress was followed by the changes of both turnover of DA and levels of BDNF protein in chronically stressed rats treated with lithium. These findings may be important in preclinical research of the effects of lithium on oxidative stress level in pathological conditions.